We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Vitamin D Status in Pediatric Asthma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01432678
Recruitment Status : Completed
First Posted : September 13, 2011
Last Update Posted : September 9, 2014
Information provided by (Responsible Party):
Orathai Piboonpocanun, Mahidol University

Brief Summary:
The purpose of this study is to evaluate level of vitamin D in pediatric asthma and relationship between vitamin D and level control of asthma.

Condition or disease
Vitamin D Deficiency

Detailed Description:
cross-sectional study

Study Type : Observational
Estimated Enrollment : 120 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Vitamin D Status in Pediatric Asthma
Study Start Date : April 2011
Primary Completion Date : June 2013
Study Completion Date : June 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Asthma Vitamin D
Drug Information available for: Vitamin D
U.S. FDA Resources

asthma patients
controlled asthma partly controlled asthma uncontrolled asthma

Biospecimen Retention:   Samples With DNA
whole blood, serum

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   6 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
allergy clinic in tertiary hospital

Inclusion Criteria:

  • children between the age of 6 years and 18 years with the diagnosis of asthma who are attending the outpatient pediatric department, pediatric allergy clinic

Exclusion Criteria:

  • patients who have chronic pulmonary, heart disease, chronic renal failure, liver disease, endrocrine disorder, or receieve antiepileptic drugs, vitamin D supplement

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01432678

Division of Allergy and Immunology, Department of Pediatrics, Faculty of medicine Siriraj Hospital, Mahidol University
Bangkok, Thailand
Sponsors and Collaborators
Mahidol University
Principal Investigator: Orathai Piboonpocanun Siriraj Hospital

Responsible Party: Orathai Piboonpocanun, Department of Pediatrics, Faculty of Medicine, Siriraj Hospital, Mahidol University
ClinicalTrials.gov Identifier: NCT01432678     History of Changes
Other Study ID Numbers: 744/2553(EC1)
First Posted: September 13, 2011    Key Record Dates
Last Update Posted: September 9, 2014
Last Verified: September 2014

Keywords provided by Orathai Piboonpocanun, Mahidol University:
vitamin D

Additional relevant MeSH terms:
Vitamin D Deficiency
Deficiency Diseases
Nutrition Disorders
Vitamin D
Growth Substances
Physiological Effects of Drugs
Bone Density Conservation Agents